Asset Valuation and Commercialisation

900

Black Swan Analysis is well positioned to help any organisation in the healthcare industry analyse and determine the potential value of their assets. Whether it is a product with clinical data, or merely a fledgling concept, Black Swan can translate this information into a suitable format.

Our team’s experience enables us to offer your organisation a range of services to suit your needs. There are three broad tiers of asset valuation that we provide which are tailored to the stage of development, time, budget & purpose for which the valuation will be used:

Tier 1

Exploratory valuation: Determines whether the product fulfils an unmet need and is financially viable.

  • Patient segmentation and sizing
  • Product utilisation and uptake benchmarks
  • Projected revenue
  • Identification of other technologies or products for a price guide
  • Generation of opportunity analysis
Tier 2

Investor valuation: Provides guidance on opportunities that require financial backing or internal investment. More advanced asset evaluation metrics will be used.

  • Development of 3 target product profiles to determine profile viability
  • Sensitivity analysis of key variables
  • Guidance to pricing based on early evaluation health economic analysis
  • Market scoping and key risk identification
  • Early asset health-economic evaluation metrics
Tier 3

Business case valuation: Encompasses a complete costing and revenue model with net present value (NPV) calculations and other key financial metrics.

  • Outline clinical program with potential end-points and cost structure
  • Full strategic business plan & exit options with deal management defined for the owners
  • Outline marketing plan with key tactics